Faculty Disclosures

Physician Faculty List & Disclosure Summary

It is the policy of the International Andreas Gruentzig Society (IAGS) to insure balance, independence, objectivity, and scientific rigor in all its sponsored educational programs. All speakers, chairpersons, panelists and planning committee members participating in this program are required to disclose to the program audience all relationships with Industry.

The intent of this policy is not to prevent a participant with an Industry Relationship from making a presentation. It is merely intended that all Industry Relationships should be identified openly so that the listeners may form their own judgments about the presentation with full disclosure of the facts. It remains for the audience to determine whether the participant’s Industry Relationships may reflect a possible bias in either the exposition or the conclusions presented.

IAGS Faculty and Writing Group Financial Disclosures

J. Dawn Abbott reports consulting (personal compensation) for Abbott (PCI), Medtronic (PCI), and Penumbra (PCI), research support (institutional, no personal compensation) for membership on the following Steering Committees: Boston Scientific, Site PI AGENT IDE trial, Med Alliance: Steering Committee, Site PI Solutions4DES, Shockwave: Site PI EMPOWER trial.

Nicolas Amoroso reports advisory board/consulting/proctoring for Nininger Medical: Advisory board, Edwards Lifesciences: Consultant, V-wave: Proctor, JenaValve: Proctor, Consultant, Abbott: Proctor, Boston Scientific: Consultant, Vdyne: Advisory board. Industry-Sponsored Trial Active/Enrolling/Research Funding: Edwards Lifesciences: CLASP II TR, RIGHT FLOW EFS, ALT-FLOW US trials, JenaValve: ALIGN-AR, Boston Scientific: ACURATE IDE, V-wave: RELIEVE-HF, AccuCinchCORCINCH: HF, Highlife: TMVR, Tendyne: SUMMIT, PreCardiaVENUS-HF.

H. V. ('Skip') Anderson reports no industry relationships.

Herbert Aronow reports consulting income from ReCor Medical, Silk Road Medical, and Philips.

Suzanne Baron reports research support (Institutional) from Boston Scientific; Abiomed; Acarix; Advisory Boards/Consulting for Boston Scientific; Medtronic; Zoll Medical; Terumo; Shockwave; Biotronik; Speaking Honoraria from Edwards LifeSciences; Medtronic; Zoll Medical; Shockwave; Boston Scientific; and Abiomed.

Itsik Ben-Dor reports no industry relationships.

Robert Bersin reports equity interest in Ablative Solutions, SA Advisory Board, Equity Interest in Med Alliance; Advisory Board, Equity Interest, Stock Options or Positions in Nectero Inc., Omeros Corp: QT Vascular, and Transverse Medical:

Douglas Cavaye reports no industry relationships.

Mauricio Cohen reports consultancy for Cordis, Abbott, Boston Scientific: ownership in Accumed Radial Systems.

Tyrone Collins reports no industry relationships.

Megan Coylewright reports research grants from Boston Scientific, Edward Lifesciences; honoraria and consulting from Boston Scientific, Edward Lifesciences, Occlutech, Medtronic, Abbott, Alleviant, American College of Cardiology CardioSmart.

Eric Dippel reports medical advisory board membership in 2MG, Abbott Vascular, Kent Imaging, Philips Symphony Suites; Speakers Bureau/Consultant in Abbott Vascular, Asahi, Becton Dickinson/CR Bard, Cordis, Kent Imaging, Medtronic, Philips. Equity in eFemoral, Nectero Medical, Synterventions. Board of director member for the Outpatient Endovascular and Interventional Society.

Darshan Doshi reports consultancy for Abbott Vascular, ACIST, Biotronik, Boston Scientific, Cordis, Medtronic, Penumbra, Philips, Shockwave, and SpectraWave; equity in Vantis and Xenter.

Dmitriy Feldman reports no industry relationships.

Tim Fischell is the CMO and a shareholder in Ablative Solutions, Inc. where he holds several licensed patents; he reports royalties and trial participation as an investigator for Cordis Corp. He is the CMO and a shareholder in Vantis Vascular, Inc. where he holds several licensed patents; He is a shareholder and receives royalties from Avertix, Inc.

Kirk Garratt reports equity in LifeCuff Technologies, Inc.

Ian Gilchrist reports equity interest in Verve Medical, Inc., and PulseGraft, Inc. He receives institutional funding from Ablative Solutions, Inc, Idorsia Pharmaceuticals, Inc., and MedAlliance, LLC

Adam Greenbaum receives honoraria from and is a speaker for Edwards Lifesciences, Medtronic: a speaker for Abbott, and receives stock options from Transmural Systems and Excision Medical.

Cindy Grines reports advisory board membership for Abiomed and Philips.

George Hanzel is a consultant for Medtronic.

Tarek Helmy has an ownership interest in Innovasc, stock in Intent Solutions, and is a clinical proctor for Medtronic (≤ $5K).

Timothy Henry reports no industry relationships.

Jimmy Kerrigan is a consultant for Abbott, Abiomed, Amgen, Asahi, Biotronik, Boston Scientific, Chiesi, Cordis, Heartflow, Ischemavie, Inc, Kardion, Kiniksa, Medtronic, Merit, Osprey Medical, Philips, Siemens, Shockwave, and Teleflex. He receives research support from Penumbra, Inari, Janssen, Prolocor, Amgen, Infraredx, and Abiomed.

Nicholas Lembo reports no industry relationships. He is a current member, American Board of Internal Medicine (ABIM) Interventional Cardiology Item-Writing Task Force.

Amir Lerman reports no industry relationships.

Ayman Magd reports no industry relationships.

J. Jeffrey Marshall is a member of the Abiomed/CRF Data and Safety Monitoring Board.

Sundeep Mishra is a consultant for Meril Life Sciences and Medtronic India.

Piotr Musialek is a proctor and/or consultant for Abbott Vascular, InspireMD, and Medtronic. He is the Global Co-PI in CGUARDIANS FDA-IDE Trial, a Polish Cardiac Society Board Representative for Stroke and Vascular Interventions, and serves on the ESC Stroke Council Scientific Documents Task Force.

Jihad Mustapha reports consultant agreements with Angiodynamics, Avinger, BD, Boston Scientific, Cardiovascular Systems, Inc., Medtronic, Micromedical Solutions, Philips, PQ Bypass, and Terumo; Equity Ownership in CardioFlow, Reflow Medical; Research for Boston Scientific, PQ Bypass, CardioFlow, and Avinger.

Srihari Naidu is a consultant for Zoll, Therox, Bristol Myers Squibb, Cytokinetics: and Chiesi.

Sigrid Nikol reports no industry relationships.

Brian O'Murchu reports no industry relationships.

William O'Neill is a consultant for Abiomed: Abbott, and Medtronic; and holds stock ownership in Synchrony Labs.

Mitul Patel is a consultant for Abbott Vascular / Cardiovascular Systems, Inc., Abiomed, Boston Scientific, Chiesi, Medtronic, Shockwave Medical, and Terumo.

Rajan Patel is an Abiomed advisory board member, and a speaker for Boston Scientific and LivaNova.

Augusto Pichard reports no industry relationships.

Ramon Quesada is a consultant speaker for Abbott, Boston Scientific: Medtronic, Philips Medical and Zoll.

Charanjit (Chet) Rihal receives research grants from Edwards Lifesciences, Innovalve; and does consulting for VDyne, Innoventric: LaPlace Interventional, and Capstan Medical.

Michael Rinaldi is a consultant for Abbott Vascular, Boston Scientific, Edwards Lifesciences, Shockwave Medical, Johnson and Johnson, Abiomed, and MiRus.

Toby Rogers is a consultant for Edwards Lifesciences: Medtronic, Boston Scientific and Transmural Systems. He is an advisory board member for Medtronic, Boston Scientific, and Transmural Systems. He has equity interest in Transmural Systems. Intellectual property: he is a co-inventor on patents, Assigned to NIH, for several transcatheter electrosurgery and ventriculoplasty devices.

Souheil Saddekni reports no industry relationships.

Jonathan Schwartz is a consultant for Abbott: Boston Scientific, Edwards Lifesciences, Medtronic:, Philips, Siemens, and Gore. He is a member of the Cordis advisory board, and receives research support from Edwards Lifesciences and Medtronic.

Binita Shah is on the Philips Volcano Advisory board, is a consultant for Boston Scientific: and on the NovaNordisk Steering committee for the ARTEMIS trial

Fayaz Shawl reports no industry relationships.

Kimberly Skelding is a proctor/consultant (Less than 10K/yr) for Medtronic:

Richard Smalling receives research support and is a consultant for Edwards Lifesciences and Abbott Vascular, receives research support from Medtronic and equity from Windmill Cardiovascular Systems. He is the CEO for Windmill Cardiovascular Systems.

Molly Szerlip is a consultant and speaker for Edwards LifeSciences; receives speaker honoraria from Boston Scientific, CVI | Cardiovascular Innovations, SCAI | Society for Cardiovascular Angiography: and Boston Scientific; she is an advisory board member for Abbott Vascular.

Jacqueline Tamis-Holland is a study co-investigator for Concepts Medical and Shockwave (with no financial relationships or decision making roles within the trials).

Charles Thompson reports no industry relationships.

Alexander Truesdell is a consultant and speakers bureau member for Abiomed, a speaker’s bureau member and stockholder for Shockwave.

George Vetrovec is a consultant for Abiomed, Merck, and for the FDA.

Bonnie Weiner reports no industry relationships.

R. Jeffrey Westcott reports no industry relationships.

B. Hadley Wilson reports no industry relationships.

David Wood is a consultant for Edwards Lifesciences, Medtronic, Boston Scientific and Abbott. He receives research grant support from Edwards Lifesciences, Medtronic, Boston Scientific and Abbott.

James Zidar is a consultant for Cordis.

The following are industry members and their disclosures: